Dyslipidemia therapy(Suzhou Sanegene Bio Inc)

血脂异常疗法（苏州圣因生物医药有限公司）

Report date: 2025/11/04 10:59:12

Base Information

Drug NameDyslipidemia therapy(Suzhou Sanegene Bio Inc)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate > Antibody-siRNA conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDyslipidemias

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesSuzhou Sanegene Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Sanegene Bio Inc

Inactive CompaniesN/A

Active IndicationsDyslipidemias

Inactive IndicationsN/A

Other Information

ATC CodeN/A